Actualités 151869.html
Alzheimer's Drugs May Work in Whole New Way, Study Finds
Thu, 12 Sep 2024 02:45:00 GMT
THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug ...